ログイン

AUBF- STRASINGER

AUBF- STRASINGER
100問 • 1年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    In the urinalysis laboratory the primary source in the chain of infection would be: A. Patients B. Needlesticks C. Specimens D. Biohazardous waste

    C. Specimens

  • 2

    2. The best way to break the chain of infection is: A. Hand sanitizing B. Personal protective equipment C. Aerosol prevention D. Decontamination

    A. Hand sanitizing

  • 3

    The current routine infection control policy developed by CDC and followed in all health-care settings is: A. Universal Precautions B. Isolation Precautions C. Blood and Body Fluid Precautions D. Standard Precautions

    D. Standard Precautions

  • 4

    An employee who is accidentally exposed to a possible blood-borne pathogen should immediately: A. Report to a supervisor B. Flush the area with water C. Clean the area with disinfectant D. Receive HIV prophylaxis

    A. Report to a supervisor

  • 5

    Personnel in the urinalysis laboratory should wear lab coats that: A. Do not have buttons B. Are fluid-resistant C. Have short sleeves D. Have full-length zippers

    B. Are fluid-resistant

  • 6

    All of the following should be discarded in biohazardous waste containers except: A. Urine specimen containers B. Towels used for decontamination C. Disposable lab coats D. Blood collection tubes

    A. Urine specimen containers

  • 7

    An employer who fails to provide sufficient gloves for the employees may be fined by the: A. CDC B. NFPA C. OSHA D. FDA

    C. OSHA

  • 8

    An acceptable disinfectant for blood and body fluid decontamination is: A. Sodium hydroxide B. Antimicrobial soap C. Hydrogen peroxide D. Sodium hypochlorite

    D. Sodium hypochlorite

  • 9

    Proper handwashing includes all of the following except: A. Using warm water B. Rubbing to create a lather C. Rinsing hands in a downward position D. Turning on the water with a paper towel

    D. Turning on the water with a paper towel

  • 10

    Centrifuging an uncapped specimen may produce a biologic hazard in the form of: A. Vectors B. Sharps contamination C. Aerosols D. Specimen contamination

    C. Aerosols

  • 11

    An employee who accidentally spills acid on his arm should immediately: A. Neutralize the acid with a base B. Hold the arm under running water for 15 minutes C. Consult the MSDSs D. Wrap the arm in gauze and go to the emergency department

    B. Hold the arm under running water for 15 minutes

  • 12

    When combining acid and water, ensure that: A. Acid is added to water B. Water is added to acid C. They are added simultaneously D. Water is slowly added to acid

    A. Acid is added to water

  • 13

    An employee can learn the carcinogenic potential of potassium chloride by consulting the: A. Chemical hygiene plan B. Material safety data sheets C. OSHA standards D. Urinalysis procedure manual

    B. Material safety data sheets

  • 14

    Employees should not work with radioisotopes if they are: A. Wearing contact lenses B. Allergic to iodine C. Sensitive to latex D. Pregnant

    D. Pregnant

  • 15

    All of the following are safe to do when removing the source of an electric shock except: A. Pulling the person away from the instrument B. Turning off the circuit breaker C. Using a glass container to move the instrument D. Unplugging the instrument

    A. Pulling the person away from the instrument

  • 16

    The acronym PASS refers to: A. Presence of vital chemicals B. Operation of a fire extinguisher C. Labeling of hazardous material D. Presence of radioactive substances

    B. Operation of a fire extinguisher

  • 17

    The system used by firefighters when a fire occurs in the laboratory is: A. MSDS B. RACE C. NFPA D. PASS

    C. NFPA

  • 18

    A class ABC fire extinguisher contains: A. Sand B. Water C. Dry chemicals D. Acid

    C. Dry chemicals

  • 19

    The first thing to do when a fire is discovered is to: A. Rescue persons in danger B. Activate the alarm system C. Close doors to other areas D. Extinguish the fire if possible

    A. Rescue persons in danger

  • 20

    If a red rash is observed after removing gloves, the employee: A. May be washing her hands too often B. May have developed a latex allergy C. Should apply cortisone cream D. Should not rub the hands so vigorously

    B. May have developed a latex allergy

  • 21

    Pipetting by mouth is: A. Acceptable for urine but not serum B. Not acceptable without proper training C. Acceptable for reagents but not specimens D. Not acceptable in the laboratory

    D. Not acceptable in the laboratory

  • 22

    The NPFA classification symbol contains information on all of the following except: A. Fire hazards B. Biohazards C. Reactivity D. Health hazards

    B. Biohazards

  • 23

    The classification of a fire that can be extinguished with water is: A. Class A B. Class B C. Class C D. Class D

    A. Class A

  • 24

    Employers are required to provide free immunization for: A. HIV B. HTLV-1 C. HBV D. HCV

    C. HBV

  • 25

    A possible physical hazard in the hospital is: A. Wearing closed-toed shoes B. Not wearing jewelry C. Having short hair D. Running to answer the telephone

    D. Running to answer the telephone

  • 26

    Quality assessment refers to: A. Analysis of testing controls B. Increased productivity C. Precise control results D. Quality of specimens and patient care

    D. Quality of specimens and patient care

  • 27

    During laboratory accreditation inspections, procedure manuals are examined for the presence of: A. Critical values B. Procedure references C. Procedures for specimen D. All of the above

    D. All of the above

  • 28

    As supervisor of the urinalysis laboratory, you have just adopted a new procedure. You should: A. Put the package insert in the procedure manual B. Put a complete, referenced procedure in the manual C. Notify the microbiology department D. Put a cost analysis study in the procedure manual

    B. Put a complete, referenced procedure in the manual

  • 29

    Indicate whether each of the following would be considered a 1) pre examination, 2) examination, or 3)post examination factor by placing the appropriate number in the blank: Reagent expiration date

    2

  • 30

    Indicate whether each of the following would be considered a 1) pre examination, 2) examination, or 3)post examination factor by placing the appropriate number in the blank: Rejecting a contaminated specimen

    1

  • 31

    Indicate whether each of the following would be considered a 1) pre examination, 2) examination, or 3)post examination factor by placing the appropriate number in the blank: Constructing a Levy-Jennings chart

    2

  • 32

    Indicate whether each of the following would be considered a 1) pre examination, 2) examination, or 3)post examination factor by placing the appropriate number in the blank: Telephoning a positive Clinitest result on a newborn

    3

  • 33

    Indicate whether each of the following would be considered a 1) pre examination, 2) examination, or 3)post examination factor by placing the appropriate number in the blank: Calibrating the centrifuge

    2

  • 34

    Indicate whether each of the following would be considered a 1) pre examination, 2) examination, or 3)post examination factor by placing the appropriate number in the blank: Collecting a timed specimen

    1

  • 35

    The testing of sample from an outside agency and the comparison of results with participating laboratories is called: A. External QC B. Electronic QC C. Internal QC D. Proficiency testing

    D. Proficiency testing

  • 36

    A color change that indicates that a sufficient amount of patient’s specimen or reagent is added correctly to the test system would be an example of: A. External QC B. Equivalent QC C. Internal QC D. Proficiency testing

    C. Internal QC

  • 37

    What steps are taken when the results of reagent strip QC are outside of the stated confidence limits? A. Check the expiration date of the reagent strip B. Run a new control C. Open a new reagent strips container D. All of the above

    D. All of the above

  • 38

    When a new bottle of QC material is opened, what information is placed on the label? A. The supervisor’s initials B. The lot number C. The date and the laboratory worker’s initials D. The time the bottle was opened

    C. The date and the laboratory worker’s initials

  • 39

    When a control is run, what information is documented? A. The lot number B. Expiration date of the control C. The test results D. All of the above

    D. All of the above

  • 40

    The average daily output of urine is: A. 200 mL B. 500 mL C. 1200 mL D. 2500 mL

    C. 1200 mL

  • 41

    An unidentified fluid is received in the laboratory with a request to determine whether the fluid is urine or another body fluid. Using routine laboratory tests, what tests would determine that the fluid is most probably urine? A. Glucose and ketones B. Urea and creatinine C. Uric acid and amino acids D. Protein and amino acids

    B. Urea and creatinine

  • 42

    The primary inorganic substance found in urine is: A. Sodium B. Phosphate C. Chloride D. Calcium

    C. Chloride

  • 43

    A patient presenting with polyuria, nocturia, polydipsia, and a low urine specific gravity is exhibiting symptoms of: A. Diabetes insipidus B. Diabetes mellitus C. Urinary tract infection D. Uremia

    A. Diabetes insipidus

  • 44

    A patient with oliguria might progress to having: A. Nocturia B. Polyuria C. Polydipsia D. Anuria

    A. Nocturia

  • 45

    All of the following are characteristics of recommended urine containers except: A. A flat bottom B. A capacity of 50 mL C. A snap-on lid D. Are disposable

    C. A snap-on lid

  • 46

    Labels for urine containers are: A. Attached to the container B. Attached to the lid C. Placed on the container prior to collection D. Not detachable

    C. Placed on the container prior to collection

  • 47

    A urine specimen may be rejected by the laboratory for all of the following reasons except the fact that the: A. Requisition states the specimen is catheterized B. Specimen contains toilet paper C. Label and requisition do not match D. Outside of the container has fecal material contamination

    D. Outside of the container has fecal material contamination

  • 48

    . A cloudy specimen received in the laboratory may have been preserved using: A. Boric acid B. Chloroform C. Refrigeration D. Formalin

    A. Boric acid

  • 49

    Prolonged exposure of a preserved urine specimen to light will cause: A. Decreased glucose B. Increased cells and casts C. Decreased bilirubin D. Increased bacteria

    C. Decreased bilirubin

  • 50

    Which of the following would be least affected in a specimen that has remained unpreserved at room temperature for more than 2 hours? A. Urobilinogen B. Ketones C. Protein D. Nitrite

    C. Protein

  • 51

    For general screening the most frequently collected specimen is a: A. Random one B. First morning C. Midstream clean-catch D. Timed

    A. Random one

  • 52

    Bacterial growth in an unpreserved specimen will: A. Decrease clarity B. Increase bilirubin C. Decrease pH D. Increase glucose

    A. Decrease clarity

  • 53

    The primary advantage of a first morning specimen over a random specimen is that it: A. Is less contaminated B. Is more concentrated C. Is less concentrated D. Has a higher volume

    B. Is more concentrated

  • 54

    If a routine urinalysis and a culture are requested on a catheterized specimen, then: A. Two separate containers must be collected B. The routine urinalysis is performed first C. The patient must be recatheterized D. The culture is performed first

    B. The routine urinalysis is performed first

  • 55

    The most sterile specimen collected is a: A. Catheterized B. Midstream clean-catch C. Three-glass D. Suprapubic

    D. Suprapubic

  • 56

    Which of the following would not be given to a patient prior to the collection of a midstream clean-catch specimen? A. Sterile container B. Iodine cleanser C. Antiseptic towelette D. Instructions

    B. Iodine cleanser

  • 57

    If a patient fails to discard the first specimen when collecting a timed specimen the: A. Specimen must be recollected B. Results will be falsely elevated C. Results will be falsely decreased D. Both A and B

    D. Both A and B

  • 58

    The primary cause of unsatisfactory results in an unpreserved routine specimen not tested for 8 hours is: A. Bacterial growth B. Glycolysis C. Decreased pH D. Chemical oxidation

    A. Bacterial growth

  • 59

    Urine specimen collection for drug testing requires the collector to do all of the following except: A. Inspect the specimen color B. Perform reagent strip testing C. Read the specimen temperature

    B. Perform reagent strip testing

  • 60

    The type of nephron responsible for renal concentration is the: A. Cortical B. Juxtaglomerular

    B. Juxtaglomerular

  • 61

    The function of the peritubular capillaries is: A. Reabsorption B. Filtration C. Secretion D. Both A and C

    D. Both A and C

  • 62

    Blood flows through the nephron in the following order: A. Efferent arteriole, peritubular capillaries, vasa recta, afferent arteriole B. Peritubular capillaries, afferent arteriole, vasa recta, efferent arteriole C. Afferent arteriole, peritubular capillaries, vasa recta, efferent arteriole D. Efferent arteriole, vasa recta, peritubular capillaries, afferent arteriole

    C. Afferent arteriole, peritubular capillaries, vasa recta, efferent arteriole

  • 63

    Filtration of protein is prevented in the glomerulus by: A. Hydrostatic pressure B. Oncotic pressure C. Renin D. The glomerular filtration barrier

    D. The glomerular filtration barrier

  • 64

    The renin-angiotensin-aldosterone system is responsible for all of the following except: A. Vasoconstriction of the afferent arteriole B. Vasoconstriction of the efferent arteriole C. Reabsorbing sodium D. Releasing aldosterone

    B. Vasoconstriction of the efferent arteriole

  • 65

    The primary chemical affected by the renin-angiotensin aldosterone system is: A. Chloride B. Sodium C. Potassium D. Hydrogen

    B. Sodium

  • 66

    Secretion of renin is stimulated by: A. Juxtaglomerular cells B. Angiotensin I and II C. Macula densa cells D. Circulating angiotensin-converting enzyme

    C. Macula densa cells

  • 67

    The hormone aldosterone is responsible for: A. Hydrogen ion secretion B. Potassium secretion C. Chloride retention D. Sodium retention

    D. Sodium retention

  • 68

    The fluid leaving the glomerulus has a specific gravity of: A. 1.005 B. 1.010 C. 1.015 D. 1.020

    B. 1.010

  • 69

    For active transport to occur, a chemical: A. Must combine with a carrier protein to create electrochemical energy B. Must be filtered through the proximal convoluted tubule C. Must be in higher concentration in the filtrate than in the blood D. Must be in higher concentration in the blood than in the filtrate

    A. Must combine with a carrier protein to create electrochemical energy

  • 70

    Which of the tubules is impermeable to water? A. Proximal convoluted tubule B. Descending loop of Henle C. Ascending loop of Henle D. Distal convoluted tubule

    C. Ascending loop of Henle

  • 71

    Glucose will appear in the urine when the: A. Blood level of glucose is 200 mg/dL B. Tm for glucose is reached C. Renal threshold for glucose is exceeded D. All of the above

    D. All of the above

  • 72

    Concentration of the tubular filtrate by the countercurrent mechanism depends on all of the following except: A. High salt concentration in the medulla B. Water-impermeable walls of the ascending loop of Henle C. Reabsorption of sodium and chloride from the ascending loop of Henle D. Reabsorption of water in the descending loop of Henle

    D. Reabsorption of water in the descending loop of Henle

  • 73

    ADH regulates the final urine concentration by controlling: A. Active reabsorption of sodium B. Tubular permeability C. Passive reabsorption of urea D. Passive reabsorption of chloride

    B. Tubular permeability

  • 74

    Decreased production of ADH: A. Produces a low urine volume B. Produces a high urine volume C. Increases ammonia excretion D. Affects active transport of sodium

    B. Produces a high urine volume

  • 75

    Bicarbonate ions filtered by the glomerulus are returned to the blood: A. In the proximal convoluted tubule B. Combined with hydrogen ions C. By tubular secretion D. All of the above

    D. All of the above

  • 76

    If ammonia is not produced by the distal convoluted tubule, the urine pH will be: A. Acidic B. Basic

    B. Basic

  • 77

    The largest source of error in creatinine clearance tests is: A. Secretion of creatinine B. Improperly timed urine specimens C. Refrigeration of the urine D. Time of collecting blood sample

    B. Improperly timed urine specimens

  • 78

    Given the following information, calculate the creatinine clearance: 24-hour urine volume: 1000 mL; serum creatinine: 2.0 mg/dL; urine creatinine: 200 mg/dL =

    69ml/min

  • 79

    Clearance tests used to determine the glomerular filtration rate must measure substances that are: A. Not filtered by the glomerulus B. Completely reabsorbed by the proximal convoluted tubule C. Secreted in the distal convoluted tubule D. Neither reabsorbed or secreted by the tubules

    D. Neither reabsorbed or secreted by the tubules

  • 80

    Performing a clearance test using radionucleotides: A. Eliminates the need to collect urine B. Does not require an infusion C. Provides visualization of the filtration D. Both A and C

    D. Both A and C

  • 81

    Variables that are included in the MDRD-IDSM estimated creatinine clearance calculations include all of the following except: A. Serum creatinine B. Weight C. Age D. Gender

    B. Weight

  • 82

    An advantage to using cystatin C to monitor GFR is that: A. It does not require urine collection B. It is not secreted by the tubules C. It can be measured by immunoassay D. All of the above

    D. All of the above

  • 83

    Solute dissolved in solvent will: A. Raise the vapor pressure B. Lower the boiling point C. Decrease the osmotic pressure D. Lower the freezing point

    D. Lower the freezing point

  • 84

    Substances that may interfere with freezing point measurement of urine and serum osmolarity include all of the following except: A. Ethanol B. Lactic acid C. Sodium D. Lipids

    C. Sodium

  • 85

    Clinical osmometers use NaCl as a reference solution because: A. 1 g molecular weight of NaCl will lower the freezing point 1.86oC B. NaCl is readily frozen C. NaCl is partially ionized similar to the composition of urine D. 1 g equivalent weight of NaCl will raise the freezing point 1.86oC

    C. NaCl is partially ionized similar to the composition of urine

  • 86

    The normal serum osmolarity is: A. 50 to 100 mOsm B. 275 to 300 mOsm C. 400 to 500 mOsm D. 3 times the urine osmolarity

    B. 275 to 300 mOsm

  • 87

    After controlled fluid intake, the urine-to-serum osmolarity ratio should be at least: A. 1:1 B. 2:1 C. 3:1 D. 4:1

    A. 1:1

  • 88

    To provide an accurate measure of renal blood flow, a test substance should be completely: A. Filtered by the glomerulus B. Reabsorbed by the tubules C. Secreted when it reaches the distal convoluted tubule D. Cleared on each contact with functional renal tissue

    D. Cleared on each contact with functional renal tissue

  • 89

    Calculate the free water clearance from the following results: urine volume in 6 hours: 720 mL; urine osmolarity: 225 mOsm; plasma osmolarity: 300 mOsm =

    +0.5

  • 90

    Given the following data, calculate the effective renal plasma flow: urine volume in 2 hours: 240 mL; urine PAH: 150 mg/dL; plasma PAH: 0.5 mg/dL = =

    600 mL/min

  • 91

    Renal tubular acidosis can be caused by the: A. Production of excessively acidic urine due to increased filtration of hydrogen ions B. Production of excessively acidic urine due to increased secretion of hydrogen ions C. Inability to produce an acidic urine due to impaired production of ammonia D. Inability to produce an acidic urine due to increased production of ammonia

    C. Inability to produce an acidic urine due to impaired production of ammonia

  • 92

    Tests performed to detect renal tubular acidosis after administering an ammonium chloride load include all of the following except: A. Urine ammonia B. Arterial pH C. Urine pH D. Titratable acidity

    B. Arterial pH

  • 93

    The concentration of a normal urine specimen can be estimated by which of the following? A. Color B. Clarity C. Foam D. Odor

    A. Color

  • 94

    The normal yellow color of urine is produced by: A. Bilirubin B. Hemoglobin C. Urobilinogen D. Urochrome

    D. Urochrome

  • 95

    The presence of bilirubin in a urine specimen produces a: A. Yellow foam when shaken B. White foam when shaken C. Cloudy specimen D. Yellow-red specimen

    A. Yellow foam when shaken

  • 96

    A. Yellow foam when shakenA urine specimen containing melanin will appear: A. Pale pink B. Dark yellow C. Blue-green D. Black

    D. Black

  • 97

    Specimens that contain hemoglobin can be visually distinguished from those that contain RBCs because: A. Hemoglobin produces a clear, yellow specimen B. Hemoglobin produces a cloudy pink specimen C. RBCs produce a cloudy red specimen D. RBCs produce a clear red specimen

    A. Hemoglobin produces a clear, yellow specimen

  • 98

    A patient with a viscous orange specimen may have been: A. Treated for a urinary tract infection B. Taking vitamin B pills C. Eating fresh carrots D. Taking antidepressants

    A. Treated for a urinary tract infection

  • 99

    The presence of a pink precipitate in a refrigerated specimen is caused by: A. Hemoglobin B. Urobilin C. Uroerythrin D. Beets

    C. Uroerythrin

  • 100

    Microscopic examination of a clear urine that produces a white precipitate after refrigeration will show: A. Amorphous urates B. Porphyrins C. Amorphous phosphates D. Yeast

    C. Amorphous phosphates

  • HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2年前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    In the urinalysis laboratory the primary source in the chain of infection would be: A. Patients B. Needlesticks C. Specimens D. Biohazardous waste

    C. Specimens

  • 2

    2. The best way to break the chain of infection is: A. Hand sanitizing B. Personal protective equipment C. Aerosol prevention D. Decontamination

    A. Hand sanitizing

  • 3

    The current routine infection control policy developed by CDC and followed in all health-care settings is: A. Universal Precautions B. Isolation Precautions C. Blood and Body Fluid Precautions D. Standard Precautions

    D. Standard Precautions

  • 4

    An employee who is accidentally exposed to a possible blood-borne pathogen should immediately: A. Report to a supervisor B. Flush the area with water C. Clean the area with disinfectant D. Receive HIV prophylaxis

    A. Report to a supervisor

  • 5

    Personnel in the urinalysis laboratory should wear lab coats that: A. Do not have buttons B. Are fluid-resistant C. Have short sleeves D. Have full-length zippers

    B. Are fluid-resistant

  • 6

    All of the following should be discarded in biohazardous waste containers except: A. Urine specimen containers B. Towels used for decontamination C. Disposable lab coats D. Blood collection tubes

    A. Urine specimen containers

  • 7

    An employer who fails to provide sufficient gloves for the employees may be fined by the: A. CDC B. NFPA C. OSHA D. FDA

    C. OSHA

  • 8

    An acceptable disinfectant for blood and body fluid decontamination is: A. Sodium hydroxide B. Antimicrobial soap C. Hydrogen peroxide D. Sodium hypochlorite

    D. Sodium hypochlorite

  • 9

    Proper handwashing includes all of the following except: A. Using warm water B. Rubbing to create a lather C. Rinsing hands in a downward position D. Turning on the water with a paper towel

    D. Turning on the water with a paper towel

  • 10

    Centrifuging an uncapped specimen may produce a biologic hazard in the form of: A. Vectors B. Sharps contamination C. Aerosols D. Specimen contamination

    C. Aerosols

  • 11

    An employee who accidentally spills acid on his arm should immediately: A. Neutralize the acid with a base B. Hold the arm under running water for 15 minutes C. Consult the MSDSs D. Wrap the arm in gauze and go to the emergency department

    B. Hold the arm under running water for 15 minutes

  • 12

    When combining acid and water, ensure that: A. Acid is added to water B. Water is added to acid C. They are added simultaneously D. Water is slowly added to acid

    A. Acid is added to water

  • 13

    An employee can learn the carcinogenic potential of potassium chloride by consulting the: A. Chemical hygiene plan B. Material safety data sheets C. OSHA standards D. Urinalysis procedure manual

    B. Material safety data sheets

  • 14

    Employees should not work with radioisotopes if they are: A. Wearing contact lenses B. Allergic to iodine C. Sensitive to latex D. Pregnant

    D. Pregnant

  • 15

    All of the following are safe to do when removing the source of an electric shock except: A. Pulling the person away from the instrument B. Turning off the circuit breaker C. Using a glass container to move the instrument D. Unplugging the instrument

    A. Pulling the person away from the instrument

  • 16

    The acronym PASS refers to: A. Presence of vital chemicals B. Operation of a fire extinguisher C. Labeling of hazardous material D. Presence of radioactive substances

    B. Operation of a fire extinguisher

  • 17

    The system used by firefighters when a fire occurs in the laboratory is: A. MSDS B. RACE C. NFPA D. PASS

    C. NFPA

  • 18

    A class ABC fire extinguisher contains: A. Sand B. Water C. Dry chemicals D. Acid

    C. Dry chemicals

  • 19

    The first thing to do when a fire is discovered is to: A. Rescue persons in danger B. Activate the alarm system C. Close doors to other areas D. Extinguish the fire if possible

    A. Rescue persons in danger

  • 20

    If a red rash is observed after removing gloves, the employee: A. May be washing her hands too often B. May have developed a latex allergy C. Should apply cortisone cream D. Should not rub the hands so vigorously

    B. May have developed a latex allergy

  • 21

    Pipetting by mouth is: A. Acceptable for urine but not serum B. Not acceptable without proper training C. Acceptable for reagents but not specimens D. Not acceptable in the laboratory

    D. Not acceptable in the laboratory

  • 22

    The NPFA classification symbol contains information on all of the following except: A. Fire hazards B. Biohazards C. Reactivity D. Health hazards

    B. Biohazards

  • 23

    The classification of a fire that can be extinguished with water is: A. Class A B. Class B C. Class C D. Class D

    A. Class A

  • 24

    Employers are required to provide free immunization for: A. HIV B. HTLV-1 C. HBV D. HCV

    C. HBV

  • 25

    A possible physical hazard in the hospital is: A. Wearing closed-toed shoes B. Not wearing jewelry C. Having short hair D. Running to answer the telephone

    D. Running to answer the telephone

  • 26

    Quality assessment refers to: A. Analysis of testing controls B. Increased productivity C. Precise control results D. Quality of specimens and patient care

    D. Quality of specimens and patient care

  • 27

    During laboratory accreditation inspections, procedure manuals are examined for the presence of: A. Critical values B. Procedure references C. Procedures for specimen D. All of the above

    D. All of the above

  • 28

    As supervisor of the urinalysis laboratory, you have just adopted a new procedure. You should: A. Put the package insert in the procedure manual B. Put a complete, referenced procedure in the manual C. Notify the microbiology department D. Put a cost analysis study in the procedure manual

    B. Put a complete, referenced procedure in the manual

  • 29

    Indicate whether each of the following would be considered a 1) pre examination, 2) examination, or 3)post examination factor by placing the appropriate number in the blank: Reagent expiration date

    2

  • 30

    Indicate whether each of the following would be considered a 1) pre examination, 2) examination, or 3)post examination factor by placing the appropriate number in the blank: Rejecting a contaminated specimen

    1

  • 31

    Indicate whether each of the following would be considered a 1) pre examination, 2) examination, or 3)post examination factor by placing the appropriate number in the blank: Constructing a Levy-Jennings chart

    2

  • 32

    Indicate whether each of the following would be considered a 1) pre examination, 2) examination, or 3)post examination factor by placing the appropriate number in the blank: Telephoning a positive Clinitest result on a newborn

    3

  • 33

    Indicate whether each of the following would be considered a 1) pre examination, 2) examination, or 3)post examination factor by placing the appropriate number in the blank: Calibrating the centrifuge

    2

  • 34

    Indicate whether each of the following would be considered a 1) pre examination, 2) examination, or 3)post examination factor by placing the appropriate number in the blank: Collecting a timed specimen

    1

  • 35

    The testing of sample from an outside agency and the comparison of results with participating laboratories is called: A. External QC B. Electronic QC C. Internal QC D. Proficiency testing

    D. Proficiency testing

  • 36

    A color change that indicates that a sufficient amount of patient’s specimen or reagent is added correctly to the test system would be an example of: A. External QC B. Equivalent QC C. Internal QC D. Proficiency testing

    C. Internal QC

  • 37

    What steps are taken when the results of reagent strip QC are outside of the stated confidence limits? A. Check the expiration date of the reagent strip B. Run a new control C. Open a new reagent strips container D. All of the above

    D. All of the above

  • 38

    When a new bottle of QC material is opened, what information is placed on the label? A. The supervisor’s initials B. The lot number C. The date and the laboratory worker’s initials D. The time the bottle was opened

    C. The date and the laboratory worker’s initials

  • 39

    When a control is run, what information is documented? A. The lot number B. Expiration date of the control C. The test results D. All of the above

    D. All of the above

  • 40

    The average daily output of urine is: A. 200 mL B. 500 mL C. 1200 mL D. 2500 mL

    C. 1200 mL

  • 41

    An unidentified fluid is received in the laboratory with a request to determine whether the fluid is urine or another body fluid. Using routine laboratory tests, what tests would determine that the fluid is most probably urine? A. Glucose and ketones B. Urea and creatinine C. Uric acid and amino acids D. Protein and amino acids

    B. Urea and creatinine

  • 42

    The primary inorganic substance found in urine is: A. Sodium B. Phosphate C. Chloride D. Calcium

    C. Chloride

  • 43

    A patient presenting with polyuria, nocturia, polydipsia, and a low urine specific gravity is exhibiting symptoms of: A. Diabetes insipidus B. Diabetes mellitus C. Urinary tract infection D. Uremia

    A. Diabetes insipidus

  • 44

    A patient with oliguria might progress to having: A. Nocturia B. Polyuria C. Polydipsia D. Anuria

    A. Nocturia

  • 45

    All of the following are characteristics of recommended urine containers except: A. A flat bottom B. A capacity of 50 mL C. A snap-on lid D. Are disposable

    C. A snap-on lid

  • 46

    Labels for urine containers are: A. Attached to the container B. Attached to the lid C. Placed on the container prior to collection D. Not detachable

    C. Placed on the container prior to collection

  • 47

    A urine specimen may be rejected by the laboratory for all of the following reasons except the fact that the: A. Requisition states the specimen is catheterized B. Specimen contains toilet paper C. Label and requisition do not match D. Outside of the container has fecal material contamination

    D. Outside of the container has fecal material contamination

  • 48

    . A cloudy specimen received in the laboratory may have been preserved using: A. Boric acid B. Chloroform C. Refrigeration D. Formalin

    A. Boric acid

  • 49

    Prolonged exposure of a preserved urine specimen to light will cause: A. Decreased glucose B. Increased cells and casts C. Decreased bilirubin D. Increased bacteria

    C. Decreased bilirubin

  • 50

    Which of the following would be least affected in a specimen that has remained unpreserved at room temperature for more than 2 hours? A. Urobilinogen B. Ketones C. Protein D. Nitrite

    C. Protein

  • 51

    For general screening the most frequently collected specimen is a: A. Random one B. First morning C. Midstream clean-catch D. Timed

    A. Random one

  • 52

    Bacterial growth in an unpreserved specimen will: A. Decrease clarity B. Increase bilirubin C. Decrease pH D. Increase glucose

    A. Decrease clarity

  • 53

    The primary advantage of a first morning specimen over a random specimen is that it: A. Is less contaminated B. Is more concentrated C. Is less concentrated D. Has a higher volume

    B. Is more concentrated

  • 54

    If a routine urinalysis and a culture are requested on a catheterized specimen, then: A. Two separate containers must be collected B. The routine urinalysis is performed first C. The patient must be recatheterized D. The culture is performed first

    B. The routine urinalysis is performed first

  • 55

    The most sterile specimen collected is a: A. Catheterized B. Midstream clean-catch C. Three-glass D. Suprapubic

    D. Suprapubic

  • 56

    Which of the following would not be given to a patient prior to the collection of a midstream clean-catch specimen? A. Sterile container B. Iodine cleanser C. Antiseptic towelette D. Instructions

    B. Iodine cleanser

  • 57

    If a patient fails to discard the first specimen when collecting a timed specimen the: A. Specimen must be recollected B. Results will be falsely elevated C. Results will be falsely decreased D. Both A and B

    D. Both A and B

  • 58

    The primary cause of unsatisfactory results in an unpreserved routine specimen not tested for 8 hours is: A. Bacterial growth B. Glycolysis C. Decreased pH D. Chemical oxidation

    A. Bacterial growth

  • 59

    Urine specimen collection for drug testing requires the collector to do all of the following except: A. Inspect the specimen color B. Perform reagent strip testing C. Read the specimen temperature

    B. Perform reagent strip testing

  • 60

    The type of nephron responsible for renal concentration is the: A. Cortical B. Juxtaglomerular

    B. Juxtaglomerular

  • 61

    The function of the peritubular capillaries is: A. Reabsorption B. Filtration C. Secretion D. Both A and C

    D. Both A and C

  • 62

    Blood flows through the nephron in the following order: A. Efferent arteriole, peritubular capillaries, vasa recta, afferent arteriole B. Peritubular capillaries, afferent arteriole, vasa recta, efferent arteriole C. Afferent arteriole, peritubular capillaries, vasa recta, efferent arteriole D. Efferent arteriole, vasa recta, peritubular capillaries, afferent arteriole

    C. Afferent arteriole, peritubular capillaries, vasa recta, efferent arteriole

  • 63

    Filtration of protein is prevented in the glomerulus by: A. Hydrostatic pressure B. Oncotic pressure C. Renin D. The glomerular filtration barrier

    D. The glomerular filtration barrier

  • 64

    The renin-angiotensin-aldosterone system is responsible for all of the following except: A. Vasoconstriction of the afferent arteriole B. Vasoconstriction of the efferent arteriole C. Reabsorbing sodium D. Releasing aldosterone

    B. Vasoconstriction of the efferent arteriole

  • 65

    The primary chemical affected by the renin-angiotensin aldosterone system is: A. Chloride B. Sodium C. Potassium D. Hydrogen

    B. Sodium

  • 66

    Secretion of renin is stimulated by: A. Juxtaglomerular cells B. Angiotensin I and II C. Macula densa cells D. Circulating angiotensin-converting enzyme

    C. Macula densa cells

  • 67

    The hormone aldosterone is responsible for: A. Hydrogen ion secretion B. Potassium secretion C. Chloride retention D. Sodium retention

    D. Sodium retention

  • 68

    The fluid leaving the glomerulus has a specific gravity of: A. 1.005 B. 1.010 C. 1.015 D. 1.020

    B. 1.010

  • 69

    For active transport to occur, a chemical: A. Must combine with a carrier protein to create electrochemical energy B. Must be filtered through the proximal convoluted tubule C. Must be in higher concentration in the filtrate than in the blood D. Must be in higher concentration in the blood than in the filtrate

    A. Must combine with a carrier protein to create electrochemical energy

  • 70

    Which of the tubules is impermeable to water? A. Proximal convoluted tubule B. Descending loop of Henle C. Ascending loop of Henle D. Distal convoluted tubule

    C. Ascending loop of Henle

  • 71

    Glucose will appear in the urine when the: A. Blood level of glucose is 200 mg/dL B. Tm for glucose is reached C. Renal threshold for glucose is exceeded D. All of the above

    D. All of the above

  • 72

    Concentration of the tubular filtrate by the countercurrent mechanism depends on all of the following except: A. High salt concentration in the medulla B. Water-impermeable walls of the ascending loop of Henle C. Reabsorption of sodium and chloride from the ascending loop of Henle D. Reabsorption of water in the descending loop of Henle

    D. Reabsorption of water in the descending loop of Henle

  • 73

    ADH regulates the final urine concentration by controlling: A. Active reabsorption of sodium B. Tubular permeability C. Passive reabsorption of urea D. Passive reabsorption of chloride

    B. Tubular permeability

  • 74

    Decreased production of ADH: A. Produces a low urine volume B. Produces a high urine volume C. Increases ammonia excretion D. Affects active transport of sodium

    B. Produces a high urine volume

  • 75

    Bicarbonate ions filtered by the glomerulus are returned to the blood: A. In the proximal convoluted tubule B. Combined with hydrogen ions C. By tubular secretion D. All of the above

    D. All of the above

  • 76

    If ammonia is not produced by the distal convoluted tubule, the urine pH will be: A. Acidic B. Basic

    B. Basic

  • 77

    The largest source of error in creatinine clearance tests is: A. Secretion of creatinine B. Improperly timed urine specimens C. Refrigeration of the urine D. Time of collecting blood sample

    B. Improperly timed urine specimens

  • 78

    Given the following information, calculate the creatinine clearance: 24-hour urine volume: 1000 mL; serum creatinine: 2.0 mg/dL; urine creatinine: 200 mg/dL =

    69ml/min

  • 79

    Clearance tests used to determine the glomerular filtration rate must measure substances that are: A. Not filtered by the glomerulus B. Completely reabsorbed by the proximal convoluted tubule C. Secreted in the distal convoluted tubule D. Neither reabsorbed or secreted by the tubules

    D. Neither reabsorbed or secreted by the tubules

  • 80

    Performing a clearance test using radionucleotides: A. Eliminates the need to collect urine B. Does not require an infusion C. Provides visualization of the filtration D. Both A and C

    D. Both A and C

  • 81

    Variables that are included in the MDRD-IDSM estimated creatinine clearance calculations include all of the following except: A. Serum creatinine B. Weight C. Age D. Gender

    B. Weight

  • 82

    An advantage to using cystatin C to monitor GFR is that: A. It does not require urine collection B. It is not secreted by the tubules C. It can be measured by immunoassay D. All of the above

    D. All of the above

  • 83

    Solute dissolved in solvent will: A. Raise the vapor pressure B. Lower the boiling point C. Decrease the osmotic pressure D. Lower the freezing point

    D. Lower the freezing point

  • 84

    Substances that may interfere with freezing point measurement of urine and serum osmolarity include all of the following except: A. Ethanol B. Lactic acid C. Sodium D. Lipids

    C. Sodium

  • 85

    Clinical osmometers use NaCl as a reference solution because: A. 1 g molecular weight of NaCl will lower the freezing point 1.86oC B. NaCl is readily frozen C. NaCl is partially ionized similar to the composition of urine D. 1 g equivalent weight of NaCl will raise the freezing point 1.86oC

    C. NaCl is partially ionized similar to the composition of urine

  • 86

    The normal serum osmolarity is: A. 50 to 100 mOsm B. 275 to 300 mOsm C. 400 to 500 mOsm D. 3 times the urine osmolarity

    B. 275 to 300 mOsm

  • 87

    After controlled fluid intake, the urine-to-serum osmolarity ratio should be at least: A. 1:1 B. 2:1 C. 3:1 D. 4:1

    A. 1:1

  • 88

    To provide an accurate measure of renal blood flow, a test substance should be completely: A. Filtered by the glomerulus B. Reabsorbed by the tubules C. Secreted when it reaches the distal convoluted tubule D. Cleared on each contact with functional renal tissue

    D. Cleared on each contact with functional renal tissue

  • 89

    Calculate the free water clearance from the following results: urine volume in 6 hours: 720 mL; urine osmolarity: 225 mOsm; plasma osmolarity: 300 mOsm =

    +0.5

  • 90

    Given the following data, calculate the effective renal plasma flow: urine volume in 2 hours: 240 mL; urine PAH: 150 mg/dL; plasma PAH: 0.5 mg/dL = =

    600 mL/min

  • 91

    Renal tubular acidosis can be caused by the: A. Production of excessively acidic urine due to increased filtration of hydrogen ions B. Production of excessively acidic urine due to increased secretion of hydrogen ions C. Inability to produce an acidic urine due to impaired production of ammonia D. Inability to produce an acidic urine due to increased production of ammonia

    C. Inability to produce an acidic urine due to impaired production of ammonia

  • 92

    Tests performed to detect renal tubular acidosis after administering an ammonium chloride load include all of the following except: A. Urine ammonia B. Arterial pH C. Urine pH D. Titratable acidity

    B. Arterial pH

  • 93

    The concentration of a normal urine specimen can be estimated by which of the following? A. Color B. Clarity C. Foam D. Odor

    A. Color

  • 94

    The normal yellow color of urine is produced by: A. Bilirubin B. Hemoglobin C. Urobilinogen D. Urochrome

    D. Urochrome

  • 95

    The presence of bilirubin in a urine specimen produces a: A. Yellow foam when shaken B. White foam when shaken C. Cloudy specimen D. Yellow-red specimen

    A. Yellow foam when shaken

  • 96

    A. Yellow foam when shakenA urine specimen containing melanin will appear: A. Pale pink B. Dark yellow C. Blue-green D. Black

    D. Black

  • 97

    Specimens that contain hemoglobin can be visually distinguished from those that contain RBCs because: A. Hemoglobin produces a clear, yellow specimen B. Hemoglobin produces a cloudy pink specimen C. RBCs produce a cloudy red specimen D. RBCs produce a clear red specimen

    A. Hemoglobin produces a clear, yellow specimen

  • 98

    A patient with a viscous orange specimen may have been: A. Treated for a urinary tract infection B. Taking vitamin B pills C. Eating fresh carrots D. Taking antidepressants

    A. Treated for a urinary tract infection

  • 99

    The presence of a pink precipitate in a refrigerated specimen is caused by: A. Hemoglobin B. Urobilin C. Uroerythrin D. Beets

    C. Uroerythrin

  • 100

    Microscopic examination of a clear urine that produces a white precipitate after refrigeration will show: A. Amorphous urates B. Porphyrins C. Amorphous phosphates D. Yeast

    C. Amorphous phosphates